Which topic describes the procedural aspect of submitting expedited ADR reports?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which topic describes the procedural aspect of submitting expedited ADR reports?

Explanation:
The main idea here is the process of reporting itself—the steps, channels, and timing for submitting expedited ADR information. “How to Report” focuses on the procedural side: what form or system to use, what information must be included, who is responsible to submit, and the timeframe for sending the report to both the sponsor and the regulatory authority. This is the aspect that governs how a report moves from identification of a serious ADR to formal notification. Why this fits best: understanding expedited reporting as a procedure is about the mechanics of submission, not just what qualifies the event or who’s responsible for handling the patient’s treatment. It covers the workflow and requirements that ensure timely, compliant communication of safety information. The other topics relate to different aspects: one deals with maintaining blinding during therapy, which is about study design and data integrity rather than reporting steps; another addresses the seriousness of an event and how that affects prioritization, not the method of how to file the report; and the last concerns the criteria that determine whether something should be reported at all, not the submission process.

The main idea here is the process of reporting itself—the steps, channels, and timing for submitting expedited ADR information. “How to Report” focuses on the procedural side: what form or system to use, what information must be included, who is responsible to submit, and the timeframe for sending the report to both the sponsor and the regulatory authority. This is the aspect that governs how a report moves from identification of a serious ADR to formal notification.

Why this fits best: understanding expedited reporting as a procedure is about the mechanics of submission, not just what qualifies the event or who’s responsible for handling the patient’s treatment. It covers the workflow and requirements that ensure timely, compliant communication of safety information.

The other topics relate to different aspects: one deals with maintaining blinding during therapy, which is about study design and data integrity rather than reporting steps; another addresses the seriousness of an event and how that affects prioritization, not the method of how to file the report; and the last concerns the criteria that determine whether something should be reported at all, not the submission process.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy